Table 2.
Clinical Course and Management during Follow-up (n=310)
| Variable | Value |
|---|---|
| Complications | |
| Acute cholangitis | 128 (41.3) |
| Liver abscess | 60 (19.4) |
| Biliary cirrhosis | 51 (16.5) |
| Cholangiocarcinoma | 23 (7.4) |
| Surgical therapy | |
| Hepatectomy | 115 (37.1) |
| Left | 98 (31.6) |
| Right | 15 (4.8) |
| Both | 2 (0.6) |
| Biliary bypass surgery* | 29 (9.4) |
| Choledocholithomy | 19 (6.1) |
| Liver transplantation | 4 (1.3) |
| Non-surgical therapy | |
| PTCSL | 53 (17.1) |
| ERCP with stone removal | 115 (37.2) |
| ERBD | 65 (21.0) |
| Follow-up duration, mo | 84.0±64.1 |
Data are presented as number (%) or mean±SD.
PTCSL, percutaneous transhepatic cholangioscopic lithotripsy; ERCP, endoscopic retrograde cholangiopancreatography; ERBD, endoscopic retrograde biliary drainage.
*
Includes choledochojejunostomy and hepaticojejunostomy.